3 Amendments of Jorgo CHATZIMARKAKIS related to 2012/0035(COD)
Amendment 30 #
Proposal for a directive
Recital 8
Recital 8
(8) Due to diversity of national measures managing the consumption of medicines, regulating their prices or establishing the conditions of their public funding it is necessary to clarify Directive 89/105/EEC. In particular this Directive should cover all types of measures devised by Member States and susceptible to impact the internal market. Since the adoption of Directive 89/105/EEC, the pricing and reimbursement procedures have evolved and have become more complex. While some Member States have interpreted the scope of Directive 89/105/EEC restrictively, the Court of Justice ruled that those pricing and reimbursement procedures fall within the scope of Directive 89/105/EEC given the objectives of that Directive and the need to ensure its effectiveness. Therefore, this Directive should reflect the developments in national pricing and reimbursement policies. Given that specific rules and procedures exist in the area of public procurement and voluntary contractual agreements, national measures involving public procIn addition to measures of direct and indirect pricing policies in accordance with objective criteria subject to evaluation, price transparency should be ensured. A distortion of competition can only be avoided through price transparency. Distorting effects in the perception of prices created by different decision making procedures in the Member States for pricing and reimbursement and voluntary contractual agreements should be excluded from the scope of this Directivebetween manufacturer and insurance carrier can be averted by more transparency of pricing methods. Improved transparency on prices leads to cost-effectiveness and cost-efficiency, as intended by this Directive. That again means cost savings for health systems.
Amendment 40 #
Proposal for a directive
Article 1 – paragraph 2 – subparagraph 1 – point a
Article 1 – paragraph 2 – subparagraph 1 – point a
Amendment 43 #
Proposal for a directive
Article 1 – paragraph 2 – subparagraph 2
Article 1 – paragraph 2 – subparagraph 2
The provisions of this Directive shall apply to measures intended to determine which medicinal products may be included in contractual agreements or public procurement procedures.